JPRN-jRCT2031230142招募中3 期
An Open-label Study of AJG555 in 1-year-old Patients with Chronic Constipation
Takeuchi Yutaka0 个研究点目标入组 26 人开始时间: 2023年6月16日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 1age old 至 < 2age old（—）
- 性别
- All
入选标准
- •1. Japanese patients with chronic constipation
- •2. Patients whose number of spontaneous bowel movements was twice a week or less on average for at least
- •1 month before obtaining informed consent
- •3. Age: 1 year (when informed consent is obtained)
排除标准
- •1. Patients with known or suspected organic constipation
- •2. Patients with megacolon and patients with encopresis
- •3. Patients with known or suspected slow intestinal transit time constipation, including symptomatic
- •constipation and drug-induced constipation
- •4. Patients with known or suspected constipation due to defecation disorder
研究者
相似试验
已完成
3 期
General Clinical Study of AJG555 in Pediatric Patients With Chronic ConstipationChronic ConstipationNCT02961556EA Pharma Co., Ltd.39
未知
3 期
Phase III study of AJG511 in patients with active ulcerative colitisulcerative colitisJPRN-jRCT2080222653EA Pharma Co.,Ltd.120
未知
3 期
Phase III Clinical Study of AJG522 : Studies of safety and efficacy of AJG522 as a colon preparation agent for colonoscopy - Comparative study with MGV-5Patients scheduled for colonoscopyJPRN-jRCT2080221438Ajinomoto Pharmaceuticals Co., Ltd.
未知
2 期
Phase II study of AJG511 in patients with active ulcerative colitislcerative colitisJPRN-jRCT2080222245Ajinomoto Pharmaceuticals Co., Ltd.
已完成
3 期
General Clinical Study of AJG555 in Pediatric Patients with Chronic ConstipatioChronic constipationJPRN-jRCT2080223327EA Pharma Co.,Ltd.39